Acceleron Pharma Inc.
Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels
Last updated:
Abstract:
In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.
Status:
Grant
Type:
Utility
Filling date:
11 Oct 2018
Issue date:
23 Jun 2020